Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas - Related Studies

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

This study has been completed.

Study NCT00001165. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Islet Cell Adenoma
		Neoplasm Metastasis
		Zollinger Ellison Syndrome

2	Additional conditions recognized in this trial
		Adenoma, Islet Cell
		Neoplasms
		Syndrome
		Zollinger-Ellison Syndrome

3	More general conditions related to this trial
		Adenoma
		Digestive System Diseases
		Digestive System Neoplasms
		Disease
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Intestinal Diseases
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Neoplastic Processes
		Pancreatic Diseases
		Pancreatic Neoplasms
		Paraneoplastic Endocrine Syndromes
		Paraneoplastic Syndromes
		Pathologic Processes
		Peptic Ulcer
		Stomach Diseases

4	Additional drug interventions recognized in this trial
		Doxorubicin
		Fluorouracil
		Streptozocin

5	More general drug interventions related to this trial
		Antibiotics, Antineoplastic
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)